Interim analysis data from phase 2 study on efficacy, safety & intratumoral pharmacokinetics of oral selinexor (KPT-330) in patients with recurrent glioblastoma (GBM) Meeting Abstract


Authors: Lassman, A. B.; Bent, Mjvd; Wen, P. Y.; Walenkamp, A.; Plotkin, S.; Kung, A.; Gardner, H.; Shacham, S.; Chudnovsky, A.; Mau-Sorensen, P. M.
Abstract Title: Interim analysis data from phase 2 study on efficacy, safety & intratumoral pharmacokinetics of oral selinexor (KPT-330) in patients with recurrent glioblastoma (GBM)
Meeting Title: 5th Quadrennial Meeting of the World Federation of Neuro-Oncology Societies (WFNOS)
Journal Title: Neuro-Oncology
Volume: 19
Issue: Suppl. 3
Meeting Dates: 2017 May 4-7
Meeting Location: Zurich, Switzerland
ISSN: 1522-8517
Publisher: Oxford University Press  
Date Published: 2017-05-01
Start Page: iii14
Language: English
ACCESSION: WOS:000402732900048
PROVIDER: wos
DOI: 10.1093/neuonc/nox036.046
PMCID: PMC5463646
Notes: Meeting Abstract: OS07.5 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Andrew L Kung
    97 Kung